- Global Pharma News & Resources

Coloplast A/S Company Profile Report, Strategic Moves, and Competitive Intelligence Report –

Pune, Maharashtra, India, September 21 2022 (Wiredrelease) Prudour Pvt. Ltd –:Introduction: Company overview

Coloplast is a Danish company that manufactures and sells medical devices, specifically ostomy, continence, urology and wound care products. The company was founded in 1957 by Elise Sørensen and her husband Holger Hesseldahl Nielsen. Coloplast is headquartered in Humlebæk, with offices and manufacturing facilities in Denmark, Sweden, France, Germany, Poland, China and the United States.

The company’s product portfolio includes over 10,000 items, ranging from simple bandages to sophisticated surgical implants. Coloplast’s ostomy care products are some of the most technologically advanced on the market. The company’s innovative products have helped to improve the lives of millions of people worldwide who live with Ostomies, incontinence or other chronic conditions.

The company operates in four business segments: Continence Care, Ostomy Care, Interventional Urology, and Wound & Skin Care. The Continence Care segment offers products for the treatment of urinary incontinence, including urethral inserts, male external catheters, and Voiding Dysfunction products. The Ostomy Care segment provides products for people with colostomies or ileostomies, such as stoma caps, bags, and skin care products. The Interventional Urology segment offers products used to treat renal diseases and urinary tract infections.

Key products and services

The company offers a wide range of products and services, including stomas, urology, continence care, wound care, and ostomy supplies. Coloplast also provides education and support to patients, families, and caregivers.

The company’s core products are Ostomy Pouches, which are used by people who have had surgery to remove all or part of their intestine or bladder. The pouches are available in a variety of sizes and styles to meet the individual needs of each patient. Coloplast also offers a line of skin barriers and adhesives to help keep the Ostomy Pouches securely in place.

Place a Direct Order of Coloplast A/S Company Profile Report@

Key Financials

Revenue (US$ Mn)

– US$ 3,066 Mn was the annual revenue generated by Coloplast A/S in 2020

– Coloplast A/S ‘s annual revenue for 2019 was US$ 2,716 Mn, a -2.78% decrease from 2018

– From 2017’s annual revenues, Coloplast A/S registered a 7.43% increase in 2018, amounting to US$ 2,794 Mn

– Total revenue of US$ 2,601 Mn was generated in 2017 by Coloplast A/S

Operating Income (US$ Mn)

– Coloplast A/S ‘s operating income for 2020 was US$ 971 Mn, a 13.3% increase from 2019

– The operating income generated by Coloplast A/S in 2019 was US$ 857 Mn

– At a 7.5% increase from , Coloplast A/S ‘s operating income of US$ 865 Mn was indexed in 2018

– Coloplast A/S generated an operating income of US$ 805 Mn in 2017

Geographical reach

With products available in over 100 countries, Coloplast has a wide geographical reach. The company has manufacturing facilities in Denmark, China and Poland, and sales offices in 30 countries. This allows Coloplast to serve customers around the world with high-quality products.

The company’s focus on innovation has led to many new products being introduced in recent years. One example is the SenSura Mio Convex one-piece ostomy system, which was launched in 2017. This product provides increased security and comfort for users, while also being easy to use.

Other Company Profile Insights :

Baxter International Inc Company Profile Report –

Cyanotech Corporation Company Profile and News –

Terumo Corporation Company Profile & Facts –

Nippi, Inc. Company Profile News, Rankings –

Herbalife Nutrition Ltd. Company Profile History Information – Business Standard –

Afrocenchix Ltd. Company profile Financial Performance, Operating Segments, Strategic Moves, and Competitive Intelligence Report –

This content has been published by Prudour Pvt. Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 21-Sep-2022